Literature DB >> 35091074

Associations between range of motion, strength, tear size, patient-reported outcomes, and glenohumeral kinematics in individuals with symptomatic isolated supraspinatus tears.

Luke T Mattar1, Adam J Popchak2, William J Anderst3, Volker Musahl4, James J Irrgang5, Richard E Debski6.   

Abstract

BACKGROUND: Clinical failure associated with nonoperative treatment of rotator cuff tears may be due to inadequate characterization of the individual's functional impairments. Clinically, restricted passive range of motion (ROM) (restrictions imply capsular tightness), limitations in muscle strength, and larger rotator cuff tears are hypothesized to be related to altered glenohumeral kinematics. Understanding these relationships, as well as the relationship between glenohumeral kinematics and patient-reported outcomes (PROs) prior to exercise therapy, may help characterize functional impairments in individuals with rotator cuff tears. The objectives of the study were to describe the baseline presentation of individuals with an isolated supraspinatus tear, including passive ROM, rotator cuff muscle strength, tear size, PROs, and glenohumeral kinematics, and to determine associations among these variables.
METHODS: One hundred one individuals with symptomatic isolated supraspinatus tears were recruited for the study and underwent assessments of passive glenohumeral ROM, isometric muscle strength, and ultrasonography to assess anterior-posterior tear size. Glenohumeral kinematics during scapular-plane abduction were measured using biplane radiography. Furthermore, PROs including the American Shoulder and Elbow Surgeons (ASES) score and the Western Ontario Rotator Cuff Index (WORC) score were collected.
RESULTS: Individuals presented with decreased ROM, external rotation weakness compared with the uninvolved side, and pain and disability as measured by the ASES and WORC scores. These findings were not associated with glenohumeral kinematics, with the exception of a weak positive association between glenohumeral contact path lengths and WORC scores (ρ = 0.25, P = .03). Tear size was 11.7 ± 5.7 mm, and maximum anterior translation, superior translation, and contact path length were 3.0% ± 3.8% of glenoid width, 3.5% ± 3.8% of glenoid height, and 38.2% ± 20.7% of glenoid size, respectively.
CONCLUSION: Individuals with a symptomatic isolated supraspinatus tear presented with decreased ROM, external rotation weakness, and pain and disability as measured by the ASES and WORC scores. However, no abnormal kinematics associated with these limitations were observed. Thus, given that the tear is isolated to the supraspinatus tendon and no capsular restrictions are present, normal function of the glenohumeral joint may be possible during scapular-plane abduction.
Copyright © 2022 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Rotator cuff tear; biomechanics; exercise therapy; glenohumeral joint; kinematics; shoulder

Mesh:

Year:  2022        PMID: 35091074      PMCID: PMC9484487          DOI: 10.1016/j.jse.2021.12.032

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.507


  58 in total

1.  Translation of the humeral head on the glenoid with passive glenohumeral motion.

Authors:  D T Harryman; J A Sidles; J M Clark; K J McQuade; T D Gibb; F A Matsen
Journal:  J Bone Joint Surg Am       Date:  1990-10       Impact factor: 5.284

2.  Validation of a new model-based tracking technique for measuring three-dimensional, in vivo glenohumeral joint kinematics.

Authors:  Michael J Bey; Roger Zauel; Stephanie K Brock; Scott Tashman
Journal:  J Biomech Eng       Date:  2006-08       Impact factor: 2.097

3.  Sonography of the rotator cuff in painful shoulders performed without knowledge of clinical information: results from 58 sonographic examinations with surgical correlation.

Authors:  Stefan Moosmayer; Stig Heir; Hans-Jørgen Smith
Journal:  J Clin Ultrasound       Date:  2007-01       Impact factor: 0.910

4.  Management of Rotator Cuff Injuries.

Authors:  Stephen Weber; Jaskarndip Chahal
Journal:  J Am Acad Orthop Surg       Date:  2020-03-01       Impact factor: 3.020

5.  Association of Strength Measurement with Rotator Cuff Tear in Patients with Shoulder Pain: The Rotator Cuff Outcomes Workgroup Study.

Authors:  Jennifer Earle Miller; Laurence D Higgins; Yan Dong; Jamie E Collins; Jonathan F Bean; Amee L Seitz; Jeffrey N Katz; Nitin B Jain
Journal:  Am J Phys Med Rehabil       Date:  2016-01       Impact factor: 2.159

6.  Ultrasonography of the rotator cuff. A comparison of ultrasonographic and arthroscopic findings in one hundred consecutive cases.

Authors:  S A Teefey; S A Hasan; W D Middleton; M Patel; R W Wright; K Yamaguchi
Journal:  J Bone Joint Surg Am       Date:  2000-04       Impact factor: 5.284

7.  Detection and quantification of rotator cuff tears. Comparison of ultrasonographic, magnetic resonance imaging, and arthroscopic findings in seventy-one consecutive cases.

Authors:  Sharlene A Teefey; David A Rubin; William D Middleton; Charles F Hildebolt; Robert A Leibold; Ken Yamaguchi
Journal:  J Bone Joint Surg Am       Date:  2004-04       Impact factor: 5.284

8.  Effects of Rotator Cuff Pathology and Physical Therapy on In Vivo Shoulder Motion and Clinical Outcomes in Patients With a Symptomatic Full-Thickness Rotator Cuff Tear.

Authors:  Timothy G Baumer; Derek Chan; Veronica Mende; Jack Dischler; Roger Zauel; Marnix van Holsbeeck; Daniel S Siegal; George Divine; Vasilios Moutzouros; Michael J Bey
Journal:  Orthop J Sports Med       Date:  2016-09-26

9.  Predictors of Pain and Functional Outcomes After the Nonoperative Treatment of Rotator Cuff Tears.

Authors:  Nitin B Jain; Gregory D Ayers; Run Fan; John E Kuhn; Keith Baumgarten; Elizabeth Matzkin; Laurence D Higgins
Journal:  Orthop J Sports Med       Date:  2018-08-03

10.  Rotator cuff tear: physical examination and conservative treatment.

Authors:  Eiji Itoi
Journal:  J Orthop Sci       Date:  2013-01-12       Impact factor: 1.601

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.